Article in Science (New York, N.Y.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Fadi E PulousCenter for Systems Biology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.ORCID 0000-0002-0794-8078
Hana SeungCenter for Systems Biology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.ORCID 0009-0004-7754-787X
Alexandre PaccaletCenter for Systems Biology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.ORCID 0000-0002-6331-562X
Charlotte G MuseCenter for Systems Biology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.ORCID 0000-0003-4412-0250
Kenneth K Y TingCenter for Systems Biology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.ORCID 0000-0002-6851-7124
Paul DelgadoCenter for Systems Biology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.ORCID 0000-0002-4554-9924
Andrew J M LewisRadcliffe Department of Medicine, NIHR Biomedical Research Centre, University of Oxford, and British Heart Foundation Centre of Research Excellence, Oxford, UK.ORCID 0000-0002-3714-6711
Vaishali KaushalDivision of Cardiac Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Antonia KresoDivision of Cardiac Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.ORCID 0000-0003-0632-958X
Dennis BrownProgram in Membrane Biology, Nephrology Division, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Sikander HayatDepartment of Medicine 2 (Nephrology, Rheumatology, Clinical Immunology Hypertension), RWTH Aachen, Medical Faculty, Aachen, Germany.ORCID 0000-0001-5919-8371
Rafael KramannDepartment of Medicine 2 (Nephrology, Rheumatology, Clinical Immunology Hypertension), RWTH Aachen, Medical Faculty, Aachen, Germany.ORCID 0000-0003-4048-6351
Filip K SwirskiCardiovascular Research Institute and Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.ORCID 0000-0002-3163-9152
Kamila NaxerovaCenter for Systems Biology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.ORCID 0000-0001-7744-5110
Daniel C PropheterDepartment of Immunology, University of Texas Southwestern Medical Center, Dallas, TX, USA.ORCID 0000-0002-8665-0885
Lora V HooperDepartment of Immunology, University of Texas Southwestern Medical Center, Dallas, TX, USA.ORCID 0000-0002-2759-4641
Michael A MoskowitzCenter for Systems Biology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Kevin R KingUniversity of California, San Diego Department of Medicine and Bioengineering, La Jolla, CA, USA.ORCID 0000-0003-1472-2189
Maarten HulsmansCenter for Systems Biology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.ORCID 0000-0003-1009-658X
Matthias NahrendorfCenter for Systems Biology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.ORCID 0000-0002-4021-1887
Funding
Pilot & Feasibility ProgramP30DK043351 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI RAYMOND T CHUNG · 1991 to 2026
$35.3M
PROJECT 4: Somatic evolution of the hematopoietic system in cardiovascular diseaseP01HL142494 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI Matthias Nahrendorf · 2019 to 2026
$19.5M
P&F programP30DK135043 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI Deborah J Wexler · 2023 to 2026
$5.4M
Cardiac resident macrophages in AV node conductionR01HL149647 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI HULSMANS, MAARTEN · 2022 to 2025
$2.9M
Macrophage heterogeneity in atrial remodelingR01HL155097 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI HULSMANS, MAARTEN · 2021 to 2025
$2.9M
Macrophages in Cardiovascular HealthR35HL176359 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI Matthias Nahrendorf · 2025 to 2026
$2.2M
The Skull Bone Marrow Niche After StrokeR37NS136068 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI Michael A. Moskowitz, Matthias Nahrendorf · 2025 to 2026
$1.6M
Biological Mechanisms of the Infarct BorderzoneR01HL181539 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Kevin R King · 2025 to 2026
$1.5M
HD Upgrade to a Nikon A1R Confocal Imaging PlatformS10OD032211 · OD · MASSACHUSETTS GENERAL HOSPITAL · PI BROWN, DENNIS · 2022 to 2022
Ventricular tachycardia disrupts the heart's coordinated pump function, leading to sudden cardiac death. Neutrophils, which are recruited in high numbers to the ischemic myocardium, promote these arrhythmias. Comparing neutrophils with macrophages, we found that resistin-like molecule γ (
Indexed as
Cell MembraneMyocytes, CardiacResistinTachycardia, VentricularAnimalsHumansImmunity, InnateMacrophagesMiceMice, Inbred C57BLMyocardial InfarctionNeutrophilsResistinRETN protein, human
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Resistin-like molecule γ attacks cardiomyocyte membranes and promotes ventricular tachycardia. · full record | OpenQuestion